Maxcyte (MXCT) Work In Process (2023 - 2026)

Maxcyte (MXCT) has 4 years of Work In Process data on file, last reported at $642000.0 in Q1 2026.

• On a quarterly basis, Work In Process rose 222.61% year-over-year to $642000.0 in Q1 2026; TTM through Mar 2026 was $642000.0, a 222.61% increase from a year earlier, with the FY2025 full-year figure at $501000.0, up 85.56% from the prior year.
• Work In Process for Q1 2026 stood at $642000.0, up from $501000.0 in the prior quarter.
• Over the last five years, Work In Process for MXCT reached as high as $1.0 million in Q2 2023 and fell as low as $101000.0 in Q2 2024.
• Historically, Work In Process has averaged $460169.2 across 4 years, with a median of $400000.0 in 2025.
• Across the five-year window, Work In Process plunged 89.93% in 2024 and soared 233.66% in 2025, its largest moves.
• Year by year, Work In Process stood at $558000.0 in 2023, then slumped by 51.61% to $270000.0 in 2024, then jumped by 85.56% to $501000.0 in 2025, then climbed by 28.14% to $642000.0 in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $642000.0 in Q1 2026, $501000.0 in Q4 2025, and $400000.0 in Q3 2025.